AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05929183 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial magnetic stimulation
Description: Setting up a new target for rTMS. In the past research, the common target of rTMS in the treatment of depressive symptom was dorsolateral prefrontal cortex (DLPFC). In this study, we use high frequency rTMS in the occipital lobe are precisely targeted by navigation, by stimulating the primary visual cortex（V1), can affect the orbitofrontal cortex (OFC), which is functionally connected to V1, and thus affect the entire nerve ring pathway excitability, thereby rapidly, effectively and safely improving mood symptoms in the acute phase of bipolar depressive episode.~After the target was determined by fMRI navigation and positioning, the subjects were subjected to rTMS for 20 minutes per day with the stimulation intensity of 10Hz and 100% of the motion threshold(MT),stimulation time of each sequence was 5 seconds, stimulation interval was 15 seconds, 3000 pulses per day for 15 days, and the total number of pulses was 45000.
Study NCT05929183 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Repetitive Transcranial magnetic stimulation
Description: The stimulus intensity was 20% of MT in the Sham Comparator arm, and the remaining parameters were the same as the Active Comparator arm.
Study NCT05667233 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Training Program
Description: Participants will undergo a high exertion machine-based resistance training protocol.
Study NCT05796076 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Virtual reality
Description: Participants in the intervention group will be received VR during the suturing procedure. Virtual reality is a three dimensions of width, height and depth that is generated digitally in a computer-generated environment that allows a user to interact with it 16.
Study NCT05094934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0385-0434 A 100 mg
Description: All participants will receive the same dose (100 mg) of the study medicine NNC0385-0434, which will be given for 10 days in a row. Participants will get the study medicine in a tablet taken orally once-daily. The study medicine needs to be taken in the morning after overnight fasting and 30 minutes before the first meal of the day.
Study NCT05094934 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NNC0385-0434 A 100 mg
Description: All participants will receive the same dose (100 mg) of the study medicine NNC0385-0434, which will be given for 10 days in a row. Participants will get the study medicine in a tablet taken orally once-daily. The study medicine needs to be taken in the morning after overnight fasting and 30 minutes before the first meal of the day.
Study NCT06416540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theraband Exercises plus Conventional Physiotherapy and Rehabilitation Program
Description: Upper extremity, shoulder flexion, abduction, elbow flexion and wrist extension movements will be applied to the study group by the physiotherapist in combination with the breathing pattern. The program will start with yellow therabant and the difficulty level will be increased according to the patient's condition. Exercise training will be applied in a total of 3 sets, 30-60 min/session, 5 days/week, 8-10 repetitions/set, depending on the condition of each patient, during the patients' stay in the intensive care unit.~Conventional Physiotherapy and Rehabilitation Program Normal joint range movements, airway clearing techniques, breathing exercises and mobilization will be applied to both groups included in the study by the physiotherapist. Hemodynamic and respiratory values for each level are monitored on the monitor. In addition, the patient will be monitored for symptoms such as blackness and dizziness by asking the patient.
Study NCT06416540 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Physiotherapy and Rehabilitation Program
Description: Normal joint range movements, airway clearing techniques, breathing exercises and mobilization will be applied to both groups included in the study by the physiotherapist. Hemodynamic and respiratory values for each level are monitored on the monitor. In addition, the patient will be monitored for symptoms such as blackness and dizziness by asking the patient.
Study NCT06416540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy and Rehabilitation Program
Description: Normal joint range movements, airway clearing techniques, breathing exercises and mobilization will be applied to both groups included in the study by the physiotherapist. Hemodynamic and respiratory values for each level are monitored on the monitor. In addition, the patient will be monitored for symptoms such as blackness and dizziness by asking the patient.
Study NCT06415825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard advice and Preliminary muscle contraction
Description: The maneuver groups will receive standard advice and an additional one - preliminary contraction of the muscles in the corresponding kinesiology segment. This advice will be embedded in all motor activities of daily living involving the relevant area.
Study NCT06415825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard advice
Description: Standard advice includes avoiding heavy physical activity, sudden and unexpected loads, repetitive and prolonged overloads, and long periods of hypomobility.
Study NCT06415825 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard advice
Description: Standard advice includes avoiding heavy physical activity, sudden and unexpected loads, repetitive and prolonged overloads, and long periods of hypomobility.
Study NCT05860894 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implantable ECG holter device (Biomonitor3, Biotronik)
Description: Subcutaneous implantation of ECG holder device to monitor ECG
Study NCT05603949 — intervention group
Intervention type: DEVICE
Intervention: 3D deep learning neural network system
Description: With the consent of the patient, we will assist in the production of images of 3D defect blocks for free (3D deep learning neural network system (3D DNN) system process planning), complete the repair and reconstruction under the clinical routine surgery, and track the repair results after surgery. meet medical needs.
Study NCT05329142 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Surplus sample toxicology analysis
Description: Anonymised surplus blood sample will be analysed for drugs and their metabolites by way of Mass Spectrometry and LGC Group, Cambridge.
Study NCT05253066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide combined with exemestane (+/- goserelin)
Description: Chidamide combined with exemestane (+/- goserelin)
Study NCT05253066 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)
Description: Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)
Study NCT06208436 — intervention group
Intervention type: OTHER
Intervention: Adjuvant chemotherapy
Description: Patients received adjuvant chemotherapy (5-FU-based or gemcitabine-based regimens) or underwent surgery alone
Study NCT05461846 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: integrated neuromuscular inhibition technique
Description: is a manual deactivation trigger points technique and includes the application of ischemic pressure and stretch, the muscle energy technique and the Strain-counterstrain technique.
Study NCT04586127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AYA NA-SB Questionnaire
Description: Questionnaire identifying cancer needs so that providers can connect subjects with services that might address them.
Study NCT06380985 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized VR Alcohol Approach Bias Modification (ApBM) Condition
Description: The Personalized VR ApBM will consist of 2D pictures representing alcohol or positive images (e.g., representing family or friends enjoying time together; sports, pets; travel and holidays, etc.) presented in a unique format in VR (e.g., landscape/portrait orientation), which will serve as the cue requiring a stimulus response. Participants are instructed to push the images away from them if they are presented in one format (e.g., landscape) and grab (using lever on VR controller) the images and pull towards themselves in response to a separate format (e.g., portrait pictures) across a virtual table. Each training session starts with 10 practice trials showing neutral objects (containers), followed by 240 training trials (120 alcohol and 120 non-alcohol trials). Training effect is achieved by altering the contingency of push vs. pull by image type (alcohol vs. positive).
Study NCT06380985 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Condition
Description: Sham training is identical to ApBM, except the contingency of each orientation (e.g., portrait or landscape) representing a push vs. a pull is altered to diminish training effect.
Study NCT05311631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding support
Description: The core of the intervention is a trustful relation between the health visitor and the families based on principles of needs based communication. Health visitors will enhance parents' action competence based on breastfeeding self-efficacy, focusing on parents' wishes and needs.~The breastfeeding support includes four main messages: joint parenting task, skin-to-skin contact, frequent breastfeeding, and good positioning.~Training of health visitors includes e-learning and a two-day course with physical attendance. Supportive materials are developed including communicative support tools and a web-page providing support and knowledge when the health visitor is off hours.~All families in intervention sites accepting the health visitor program will receive the improved breastfeeding support. Families in the high-risk group are offered an intensified intervention with close follow-up by telephone in planned time-intervals, thus a higher dose of the intervention.
Study NCT06048276 — intervention group
Intervention type: DRUG
Intervention: Herbal medicines (e.g., Yunkang granules, Duzhong granules)
Description: Herbal medicines (e.g., Yunkang granules, Duzhong granules) exposure at the early gestation.
Study NCT05616793 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AAV8.hLCA5
Description: Adeno-associated virus vector expressing human LCA5 gene
Study NCT05228678 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cardiopulmonary exercise tests
Description: Spirometry~* forced expiratory volume in 1 second (FEV1) % predicted,~* forced vital capacity (FVC)% predicted,~* forced expiratory volume in 1 second /forced vital capacity FEV1 /FVC
Study NCT05117346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CARDIX-101A, CARDIX-101B, CARDIX-101C
Description: Each subject will receive, via oral administration, one capsule of study medicine per dose and three doses per day for 14±2-days treatment.
Study NCT06291194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AJU-S56 5%
Description: After Randomization(Week 0), Participants will be administered with the durg, QID(4 times in a day, and 1 drop per each times) until end of trial(Week 24).
Study NCT06291194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group(Vehicle)
Description: After Randomization(Week 0), Participants will be administered with the durg, QID(4 times in a day, and 1 drop per each times) until end of trial(Week 24).
Study NCT06550609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miltefosine Oral Capsule
Description: Miltefosine 3 pill per day during 28 days AND pentamidine inhaled 300 mg / d during 10 dosis
Study NCT06243276 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: One stage implant surgery
Description: It is a technique in which the healing cap is connected to the implant at the stage of implant placement.
Study NCT06243276 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Two stage implant surgery
Description: It is a technique in which the healing cap is connected to the implant three months after the implant is placed.
Study NCT06361927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSGJ-707
Description: bispecific antibody
Study NCT00012922 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Low Literacy Intervention for Colorectal Cancer Screening
Study NCT06560411 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-Invasive Ventilation
Description: Provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation
Study NCT06299787 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intermittent theta burst stimulation
Description: Theta-burst stimulation
Study NCT06299787 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: Stimulation with double-sided B70-type coil
Study NCT05786911 — intervention group
Intervention type: OTHER
Intervention: nutritional score
Description: correlation between a food habit and nutritional status score of the parturient and a postpartum fatigue (FSS) and pain (ENA) score
Study NCT03653728 — intervention group
Intervention type: DEVICE
Intervention: Near infrared spectroscopy
Description: All patients would be receiving the same treatment including application of non-invasive monitoring with near-infrared spectroscopy (NIRS) together with the standard of care with interval CT Brain scan for all patients.~Non-invasive monitoring with near-infrared spectroscopy (NIRS) is very safe and is in current daily routine clinical use for intraoperative patients.
Study NCT05510336 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthrocentesis
Description: Injection of lactated ringer solution in the TMJ to wash out inflammatory mediators and help reducing anterior disc displacement with reduction
Study NCT04955327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: A. Paniculata
Description: Extract from A. Paniculata
Study NCT04955327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: A. Chilensis
Description: Extract from A. Chilensis
Study NCT06529471 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage group
Description: The patient in the massage group will be visited by the practitioner 3 times at 10:00-14:00-20:00 on the first day after surgery and a back massage will be applied. The patient in the massage group will be placed in an orthopnea position during the application. The massage procedure lasts an average of 30 minutes and is applied to the cervical 3 and thoracic 12 vertebrae.
Study NCT06239077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non Invasive Prenatal Test via blood sample
Description: Maternal - blood draw, Paternal - blood draw/Saliva sample
Study NCT03527537 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Insulin may be administered base on glucose log values. The dosing of the insulin will be determined by the provider using typical management of gestational diabetes.
Study NCT05244122 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feedback
Description: presence or absence of trial by trial feedback
Study NCT05244122 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prevalence
Description: In some blocks, skin cancer target images were present on 50% of trials (high prevalence). In other blocks, disease prevalence was 20%.
Study NCT04812301 — intervention group
Intervention type: RADIATION
Intervention: Egg-white sandwich
Description: 1 mCi of Tc-99m sodium phytate is added into the egg-white sandwich
Study NCT04812301 — intervention group
Intervention type: RADIATION
Intervention: Abbott Vital®
Description: 1 mCi of Tc-99m sodium phytate is added into the Abbott Vital®
Study NCT05463315 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Moziak Device
Description: Applying Moziak Device Compared to Standard Manual Compression
Study NCT05507840 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Valeda machine
Description: Photobiomodulation treatment with Valeda machine will be applied every six months for 2 years in patients with dry age related macula degeneration.
Study NCT05507840 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Valeda machine
Description: Photobiomodulation treatment with Valeda machine will be applied every six months for 2 years in patients with dry age related macula degeneration.
Study NCT05946564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone (ACTOS®)
Description: Patient will be randomize in the intervention group receive treatment by pioglitazone (30 mg/day orally) for 26 weeks on top of a SOC immunosuppressive treatment.
Study NCT05946564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of Pioglitazone
Description: Patient will be randomize in the intervention group receive treatment by placebo of pioglitazone (30 mg/day orally) for 26 weeks on top of a SOC immunosuppressive treatment.
Study NCT05682638 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: LVRNA009
Description: 100μg/1.0ml/dose(50 μg/0.5ml/Vial), 2 injection with 28 days apart
Study NCT05682638 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LVRNA009
Description: 100μg/1.0ml/dose(50 μg/0.5ml/Vial), 2 injection with 28 days apart
Study NCT05682638 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9%NaCl
Description: 1.0ml/dose, 2 injection with 28 days apart
Study NCT05682638 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 0.9%NaCl
Description: 1.0ml/dose, 2 injection with 28 days apart
Study NCT06146010 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Once the patient or their legal guardian has given their written consent, a patient is included in the leptomeningeal disease register. Due to the rapid course of the disease and potential rapid deterioration, the documentation of the course of the disease of the individual patients is to be carried out retrospectively from the data recorded during the course of the clinical routine for the entire duration of the study or until the death of the participating patients after the written consent of the patients. The registry's data sources are the diagnostic findings made at the center and doctors' letters from routine clinical practice. The participating centers carry out the assessment of the participants' performance status so that the patients do not have to complete any study-related questionnaires.
Study NCT04819243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib, Atezolizumab
Description: * Palbociclib 125mg~* AI~* GnRH agonist (or ET + CDK4/6 inhibitors + GnRH agonist)~* Talazoparib~* Atezolizumab
Study NCT04819243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib,
Description: * Palbociclib 125mg~* AI~* GnRH agonist (or ET + CDK4/6 inhibitors + GnRH agonist)~* Talazoparib
Study NCT06026163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Description: Caffeine citrate in loading dose 20 mg/kg (equivalent for 10 mg/kg caffeine base) and maintenance dose 10 mg/kg/day (equivalent for 5 mg/kg caffeine base)
Study NCT06026163 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Equivalent volume of saline
Study NCT05057494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Dose formulation: Capsule or Tablet
Study NCT05057494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Dose formulation: Tablet
Study NCT05057494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Dose formulation: Injection
Study NCT04955327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: A. Paniculata and A. Chilensis
Description: Combination of A. Paniculata and A. Chilensis
Study NCT04955327 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline cellulose
Description: Placebo comparator
Study NCT06145100 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound including color doppler ultrasound
Description: Patients with CVID receive color doppler ultrasound of the liver including assessment of portal vein diameter, portal vein flow velocity, hepatic vein diameter and assessment of arterial perfusion. Further liver and spleen stiffness measurement by transient elastography is performed.
Study NCT05896800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nitric Oxide Generation and Delivery System
Description: The Nitric Oxide Generation and Delivery System is used to deliver nitric oxide for inhalation therapy into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user, to the patient throughout the inspired breath.
Study NCT06460805 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Partial enteral nutrition
Description: 70% caloric intake from enteral nutrition formula and 30% caloric intake from a limited range of solid foods
Study NCT04814173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-jaw mechanic total maxillary arch distalization
Description: A group of patients in which participants will be undergo to the one-jaw mechanic for mini-implants anchored total-maxillary-arch-distalization (the mini-implants will be inserted in the maxillary arch between the roots of 2nd premolar and 1st molar and closer to the molar, then a force of 250 g will be applied from the TAD to a hook lateral to the laterals).